Pharmaceuticals announced a streamlined strategic focus on advancing and realizing the potential of apraglutide for the ...
State Auditor Diana DiZoglio released an audit of settlement agreements and confidentiality clauses across state agencies and ...
State Auditor Diana DiZoglio on Tuesday charged that Massachusetts is relying on a “broken system” for both executing and ...
Restrictive covenants could limit workers’ ability to report discrimination and harassment, two Lift Our Voices studies ...
Highlights faulty FDA review WASHINGTON, Jan. 27, 2025 /PRNewswire/ -- Vanda Pharmaceuticals Inc. (Vanda) (Nasdaq: VNDA) today provides an update on the tradipitant ...
Download the detailed syllabus PDF here. Check the section-wise topics, exam pattern, preparation strategy, and best books.
Bitopertin is an investigational agent and is not approved for use as a therapy in any jurisdiction worldwide. Disc obtained global rights to bitopertin under a license agreement from Roche in May ...
Arrowhead Pharmaceuticals, Inc. (NASDAQ: ARWR) today announced that the U.S. Food and Drug Administration (FDA) has accepted ...
Beacon (Nasdaq: BECN) (the "Company") today confirmed that it has previously received and rejected an unsolicited, non-binding proposal from QXO, Inc. (Nasdaq: QXO) to acquire all outstanding shares ...
Israel and Hamas have reached a ceasefire agreement that would put a stop to more than a year of fighting, according to multiple reports. A Hamas official told Sky News and several other outlets that ...
Contrary to QXO’s assertions, Beacon offered on multiple occasions to engage, including to discuss price, subject only to a standard non-disclosure agreement (NDA). Additionally, Beacon ...